FDA approves once-daily Zerit
BY Advocate.com Editors
January 03 2003 1:00 AM ET
The Food and Drug Administration on Tuesday approved a new, extended-release form of the HIV nucleoside reverse transcriptase inhibitor Zerit (d4T), which will be marketed as Zerit XR by drugmaker Bristol-Myers Squibb. The new formulation can be taken just once a day. Data from clinical trials of the medication show that it is as effective as the standard twice-daily dosing of d4T and that reducing the pill burden may help people with HIV better stick to their anti-HIV drug regimens.
- Op-ed: 'Religious Discrimination' Laws Have Nothing to Do With Religion
- Indiana Newspaper Sends Big Message
- Subaru Comes Out Against Indiana's 'License to Discriminate'
- Op-ed: Angelina Jolie's Choice Bolsters the Trans Argument
- Mormon Missionary Positions
- These Indiana Businesses Haven't Weighed in on Discrimination